GM-CSF (Human) OmniKine ELISA Kit

Catalog No.

OK-0118

Size

12 x 8-Well Microstrips

Price

530.00€

Buy

Product details

Description

The OmniKine Human GM-CSF ELISA can be used to recognize both of recombinant and naturally produced (by human) Human GM-CSF proteins. The following antigens were tested at 50 ng/ml and did not showed a significant interference or cross reactivity. • Human: G-CSF, IL-5, SCF, M-CSF, TPO, • Murine: G-CSF, M-CSF, GM-CSF • Rat: GM-CSF.

Target Name

Human GM-CSF

Assay Type

Sandwich ELISA

Detection Method

Colorimetric 450 nm

Synonyms

CSF, Molgramostin, Sargramostim, Colony-stimulating factor, Granulocyte-macrophage colony-stimulating factor.

NCBI Gene Symbol

CSF2

Storage

4°C

Stability

6 Months

Dynamic Range

32-1000 pg/ml

Recommended use

Research use only

Contact us

Technical Service

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Properties

E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Test

ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED

Gene

Granulocyte-macrophage colony-stimulating factor (GM-CSF), also known as colony stimulating factor 2 (CSF2), is a monomeric glycoprotein secreted by macrophages, T cells, mast cells, NK cells, endothelial cells and fibroblasts that functions as a cytokine. The pharmaceutical analogs of naturally occurring GM-CSF are called sargramostim and molgramostim. Reconstitution It is recommended that sterile ddH2O containing at least 0.1% human serum albumin or bovine serum albumin be added to the vial to prepare a stock solution of not less than 1 mg/mL of the cytokine.